Lupus Research Alliance Announces Recipients of the Lupus Mechanisms and Targets Award
The Lupus Research Alliance (LRA) is pleased to announce the recent recipients of the Lupus Mechanisms and Targets Award...
Chandra Mohan
Lupus Nephritis: A Major Focus at the Lupus Research Alliance
Updated March, 2022
Developing safe and effective treatments for lupus nephritis has been an urgent and long-standing goal in the...
LRA Congratulates Equillium on Positive Results of Study of Potential New Lupus Treatment
March 30, 2021
Equillium, Inc. announced positive topline data from the phase 1b EQUALISE study in patients with systemic lupus...
Lupus Research Program – Driven by LRA Advocacy – Announces 10 New Grant Recipients
March 19, 2021
Ten new applications for promising scientific studies were just recommended for funding by the Lupus Research Program...
The LRA’s Forum for Discovery: Sharing the Latest News in Lupus Research
The Lupus Research Alliance (LRA) held our annual scientific conference, the Forum for Discovery, online in true 2020 fashion....
Lupus Research Alliance Announces 10 Recipients of New Award in Partnership with Bristol Myers Squibb
NEW YORK, NY. July 14, 2020 -- The Lupus Research Alliance (LRA) is pleased to announce the recipients of...
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019
The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly...
LRA Pleased to Share News of Lupus Nephritis Clinical Trial Launch
October 1, 2019
The Lupus Research Alliance is pleased to share news about the launch of EQUALISE, a Phase 1b...
LRA-Funded Researcher Finds New Biomarkers for Lupus Nephritis
August 7, 2019
Dr. Chandra Mohan discovered that blood clotting proteins are higher in the urine of people with lupus...
New Approach to Treating Lupus Nephritis
February 6, 2019
Scientists partly funded by the Lupus Research Alliance have found a potential new way to protect the...